Skip to content

Clinical trials

Essential Hypertension trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: Switzerland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20071
20081
20111
20141
20151
20182
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis3
Insel Gruppe AG, University Hospital Bern2
Sankyo Pharma Gmbh2
Centre Hospitalier Universitaire Vaudois1
Novartis Pharmaceuticals1
Orchestra BioMed, Inc1
ReCor Medical, Inc.1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension12
Hypertension9
Cardiovascular Diseases1
Edema1
Hypercholesterolemia1
Isolated Systolic Hypertension1
Vascular Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.